Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$145.45
-0.15-0.1%
Last update: Oct 12, 4:56 PM
$145.66
0.06080.04%
Merck & Co Inc (MRK) Stock Price, Quote, News & History
MRKNYSE
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Merck & Co (NYSE:MRK) through any online brokerage.
Other companies in Merck & Co’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Novartis AG (NYSE:NVS), AstraZeneca PLC (NYSE:AZN) and Novo Nordisk AS (NYSE:NVO).
Merck & Co has a consensus price target of $145.00.
The stock price for Merck & Co (NYSE: MRK) is $145.6608 last updated October 12, 2026 at 4:56 PM EDT.
There are no upcoming dividends for Merck & Co.
Merck & Co does not have any upcoming earnings scheduled.
There is no upcoming split for Merck & Co.
Merck & Co is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.
